Exploratory investigation of discovering novel biomarker to predict efficacy of chemotherapy ncluding bevacizumab in patients with advanced ovarian cancer
Not Applicable
- Conditions
- Advanced ovarian cancer
- Registration Number
- JPRN-UMIN000022481
- Lead Sponsor
- Gunma University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1) Pregnant woman 2) Patients with double primary cancer or serious infectious disease requring antibiotic therapy 3) Other cases attending physician it is determined unsuitable for registration of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method